9 years since the report of a cure for HIV after CC chemokine receptor type 5 Δ32 stem cell
transplantation, no other case of HIV cure has been reported, despite much research …

Remarkable advances are being made in develo** interventions for eliciting long-term
remission of HIV-1 infection. The success of these interventions will obviate the need for …

A cure for HIV-1 remains unattainable as only one case has been reported, a decade ago,.
The individual—who is known as the 'Berlin patient'—underwent two allogeneic …

HIV cure has been reported for five individuals who underwent allogeneic hematopoietic
stem cell transplantation (allo-HSCT) with cells from CCR5Δ32 homozygous donors. By …

In HIV-infected individuals on long-term antiretroviral therapy (ART), more than 40% of the
infected cells are in clones. Although most HIV proviruses present in individuals on long …

Although antiretroviral therapy is able to suppress HIV replication in infected patients, the
virus persists and rebounds when treatment is stopped. In order to find a cure that can …

Background Allogeneic haematopoietic stem-cell transplantation (allo-HSCT) markedly
reduces HIV reservoirs, but the mechanisms by which this occurs are only partly understood …

Combination antiretroviral therapy (ART) for HIV-1 infection reduces plasma virus levels
such that clinical assays for viremia are negative. Because of unexpected cooperativity in …

Chimeric antigen receptor (CAR) T cells targeting CD19+ hematologic malignancies have
rapidly emerged as a promising, novel therapy. In contrast, results from the few CAR T-cell …

Antiretroviral therapy cannot cure HIV-1 infection due to the persistence of a small number of
latently infected cells harboring replication-competent proviruses. Measuring persistent HIV …